SPRY ARS PHARMACEUTICALS INC
2026Q1 · CUSIP 82835W108 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
202
Δ holders QoQ
+11
Breadth percentile
Top 27%
Whale holders
95
Δ whales
+8
Inst. holding value
$750M
New positions
40
Closed positions
29
Price momentum (1Q)
-22.2%
Put / Call
2/4
Breadth history (34 quarters)
Past Lit Events & Aftermath 3 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q1 | Top 12% | -3.3% | -48.7% |
| 2024Q3 | Top 8% | -18.4% | +5.4% |
| 2023Q1 | Top 10% | -18.8% | -45.4% |
Options Sentiment
Put holders
2
QoQ: 0
Call holders
4
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-2.00
EPS YoY
—
Revenue (TTM)
$0.1B
Revenue YoY
+1.9%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)